EUVIMEDEUVIMED entdecken
Crossref

Recent Advances in Autism Spectrum Disorder: Etiological Mechanisms and Integrated Treatment Approaches

Dhamya Kadhim Sarhan, Maysam Ali Eidans, Attyaf Jameel Thamir

Healthcare Issues · 13.10.2026 · 5 (2) · 26

DOI: 10.58614/hi525 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Healthcare Issues, online erschienen am 13.10.2026. Verfasst von Dhamya Kadhim Sarhan und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Autism Spectrum Disorder (ASD) is a multifaceted neurodevelopmental disorder defined by long-term difficulties in social communication with restricted, repetitive behaviors. The field has recently expanded its understanding of the multifactorial nature of the disorder and broadened therapeutic approaches toward targeted, neurodiversity-affirming interventions. Etiology: The architecture of ASD itself is based on a dynamic interaction between heritable genetic risk (including polygenic risk scores, CNVs and de novo mutations) and also environmental effects involving maternal immune activation, advanced parental age, prenatal exposure to chemicals, etc. Pathophysiologically, these contributors converge on synaptic dysregulation, abnormal cortical microcircuitry connectivity, systemic neuroinflammation and gut microbiome dysbiosis. Therapeutic Paradigms: Contemporary interventions have transitioned from generic symptom management toward biological, behavioral, and precision-driven modalities: • Neuromodulation Therapies: Non-invasive rTMS and tDCS targeting prefrontal regions to alter neural plasticity and executive function. • Microbiota-Gut-Brain (MGB) Axis Interventions: Dietary modification, targeted pre/probiotics, and Fecal Microbiota Transplantation (FMT) aimed at reducing neuroinflammation. • Naturalistic Developmental Behavioral Interventions (NDBIs): Frameworks like ESDM and JASPER that integrate behavioral learning into child-led, naturalistic contexts. • Biomarker-Targeted Pharmacotherapy: Precision agents addressing pathwayspecific mechanisms, such as oxytocinergic regulators and GABAergic modulators. • Digital Therapeutics (DTx) & VR: Virtual reality social training and AI-driven platforms delivering adaptive, tailored skill training in low-anxiety environments.

Conclusion

Bridging etiological insights with multimodal therapeutic paradigms is critical for subgrouping ASD phenotypes, optimizing individual treatment responses, and guiding future clinical research.

Zitieren

APA

Sarhan, D. K., Eidans, M. A., & Thamir, A. J. (2026). Recent Advances in Autism Spectrum Disorder: Etiological Mechanisms and Integrated Treatment Approaches. Healthcare Issues, 5(2), 26. https://doi.org/10.58614/hi525

Vancouver

Sarhan DK, Eidans MA, Thamir AJ. Recent Advances in Autism Spectrum Disorder: Etiological Mechanisms and Integrated Treatment Approaches. Healthcare Issues. 2026;5(2):26. doi:10.58614/hi525

BibTeX
@article{Sarhan2026,
  author = {Sarhan, Dhamya Kadhim and Eidans, Maysam Ali and Thamir, Attyaf Jameel},
  title = {Recent Advances in Autism Spectrum Disorder: Etiological Mechanisms and Integrated Treatment Approaches},
  journal = {Healthcare Issues},
  year = {2026},
  volume = {5},
  number = {2},
  pages = {26},
  doi = {10.58614/hi525}
}
Kostenlos starten →